|
C12ORF51 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.24975635080227E-14 |
| Normal-vs-Stage2 |
2.41099999964689E-07 |
| Normal-vs-Stage3 |
1.11022302462516E-16 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
2.642400E-01 |
| Stage1-vs-Stage3 |
4.488200E-02 |
| Stage1-vs-Stage4 |
3.827600E-04 |
| Stage2-vs-Stage3 |
1.106060E-02 |
| Stage2-vs-Stage4 |
1.362350E-03 |
| Stage3-vs-Stage4 |
1.708400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.88178419700125E-16 |
| Normal-vs-AfricanAmerican |
1.94580000001388E-07 |
| Normal-vs-Asian |
1.63757896132211E-12 |
| Caucasian-vs-AfricanAmerican |
5.770200E-01 |
| Caucasian-vs-Asian |
4.975400E-01 |
| AfricanAmerican-vs-Asian |
2.434000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.49560397189452E-14 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
6.736200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
1.66644475996236E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62470037423645E-12 |
| Normal-vs-Age(81-100Yrs) |
1.155100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.417000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.476200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.629200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.149800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.545800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.312800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.18579999988755E-07 |
| Classical-VS-Follicular |
1.065600E-01 |
| Classical-VS-Other |
9.425600E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
5.62960000000112E-05 |
| Tall-VS-Other |
1.117430E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
4.308400E-01 |
| Follicular-VS-Normal |
1.22540000002669E-06 |
| Other-VS-Normal |
7.009100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.33066907387547E-16 |
| Normal-vs-N1 |
4.44089209850063E-16 |
| N0-vs-N1 |
1.967940E-02 |
|
|
